Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 3
2021 4
2022 4
2023 2

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity.
Hailemichael Y, Johnson DH, Abdel-Wahab N, Foo WC, Bentebibel SE, Daher M, Haymaker C, Wani K, Saberian C, Ogata D, Kim ST, Nurieva R, Lazar AJ, Abu-Sbeih H, Fa'ak F, Mathew A, Wang Y, Falohun A, Trinh V, Zobniw C, Spillson C, Burks JK, Awiwi M, Elsayes K, Soto LS, Melendez BD, Davies MA, Wargo J, Curry J, Yee C, Lizee G, Singh S, Sharma P, Allison JP, Hwu P, Ekmekcioglu S, Diab A. Hailemichael Y, et al. Among authors: saberian c. Cancer Cell. 2022 May 9;40(5):509-523.e6. doi: 10.1016/j.ccell.2022.04.004. Epub 2022 May 9. Cancer Cell. 2022. PMID: 35537412 Free PMC article.
Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature.
Safa H, Johnson DH, Trinh VA, Rodgers TE, Lin H, Suarez-Almazor ME, Fa'ak F, Saberian C, Yee C, Davies MA, Tummala S, Woodman K, Abdel-Wahab N, Diab A. Safa H, et al. Among authors: saberian c. J Immunother Cancer. 2019 Nov 21;7(1):319. doi: 10.1186/s40425-019-0774-y. J Immunother Cancer. 2019. PMID: 31753014 Free PMC article. Review.
Lag3: From Bench to Bedside.
Aroldi F, Saleh R, Jafferji I, Barreto C, Saberian C, Middleton MR. Aroldi F, et al. Among authors: saberian c. Cancer Treat Res. 2022;183:185-199. doi: 10.1007/978-3-030-96376-7_6. Cancer Treat Res. 2022. PMID: 35551660 Review.
A New Era For Tattoos, with New Potential Complications.
Maarouf M, Saberian C, Segal RJ, Shi VY. Maarouf M, et al. Among authors: saberian c. J Clin Aesthet Dermatol. 2019 Feb;12(2):37-38. Epub 2019 Feb 1. J Clin Aesthet Dermatol. 2019. PMID: 30881582 Free PMC article.
Targeted therapy strategies for melanoma brain metastasis.
Saberian C, Sperduto P, Davies MA. Saberian C, et al. Neurooncol Adv. 2021 Nov 27;3(Suppl 5):v75-v85. doi: 10.1093/noajnl/vdab131. eCollection 2021 Nov. Neurooncol Adv. 2021. PMID: 34859235 Free PMC article.
Changes in outcomes and factors associated with survival in melanoma patients with brain metastases.
Hasanov M, Milton DR, Davies AB, Sirmans E, Saberian C, Posada EL, Opusunju S, Gershenwald JE, Torres-Cabala CA, Burton EM, Colen RR, Huse JT, Glitza Oliva IC, Chung C, McAleer MF, McGovern SL, Yeboa DN, Kim BYS, Prabhu SS, McCutcheon IE, Weinberg JS, Lang FF, Tawbi HA, Li J, Haydu LE, Davies MA, Ferguson SD. Hasanov M, et al. Among authors: saberian c. Neuro Oncol. 2023 Jul 6;25(7):1310-1320. doi: 10.1093/neuonc/noac251. Neuro Oncol. 2023. PMID: 36510640 Free PMC article.
14 results